You are viewing the site in preview mode

Skip to main content

Table 2 Characteristics of the studied population

From: Molecular detection of urogenital mollicutes in patients with invasive malignant prostate tumor

  PCa (n = 50) BPH (n = 55)
Age (years)
 < 60 2 (4%) 5 (9%)
 60–69 9 (18%) 17 (31%)
 70–79 23 (46%) 22 (40%)
 > 79 16 (32%) 11 (20%)
PSA level (ng/ml)
 0–4 4 (8%) 17 (31%)
 4.1–10 7 (14%) 17 (31%)
 10.1–20 8 (16%) 14 (25%)
 > 20 31 (62%) 7 (13%)
Gleason score
 6–7 12 (24%)
 8–10 38 (76%)
  1. PCa Prostate Cancer, BPH Benign Prostate Hyperplasia, PSA Prostate Specific Antigen
\